Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration
dc.contributor.author | Willeit, P. | |
dc.contributor.author | Thompson, S. | |
dc.contributor.author | Agewall, S. | |
dc.contributor.author | Bergström, G. | |
dc.contributor.author | Bickel, H. | |
dc.contributor.author | Catapano, A. | |
dc.contributor.author | Chien, K. | |
dc.contributor.author | De Groot, E. | |
dc.contributor.author | Empana, J. | |
dc.contributor.author | Etgen, T. | |
dc.contributor.author | Franco, O. | |
dc.contributor.author | Iglseder, B. | |
dc.contributor.author | Johnsen, S. | |
dc.contributor.author | Kavousi, M. | |
dc.contributor.author | Lind, L. | |
dc.contributor.author | Liu, J. | |
dc.contributor.author | Mathiesen, E. | |
dc.contributor.author | Norata, Giuseppe | |
dc.contributor.author | Olsen, M. | |
dc.contributor.author | Papagianni, A. | |
dc.contributor.author | Poppert, H. | |
dc.contributor.author | Price, J. | |
dc.contributor.author | Sacco, R. | |
dc.contributor.author | Yanez, D. | |
dc.contributor.author | Zhao, D. | |
dc.contributor.author | Schminke, U. | |
dc.contributor.author | Bülbül, A. | |
dc.contributor.author | Polak, J. | |
dc.contributor.author | Sitzer, M. | |
dc.contributor.author | Hofman, A. | |
dc.contributor.author | Grigore, L. | |
dc.contributor.author | Dörr, M. | |
dc.contributor.author | Su, T. | |
dc.contributor.author | Ducimetière, P. | |
dc.contributor.author | Xie, W. | |
dc.contributor.author | Ronkainen, K. | |
dc.contributor.author | Kiechl, S. | |
dc.contributor.author | Rundek, T. | |
dc.contributor.author | Robertson, C. | |
dc.contributor.author | Fagerberg, B. | |
dc.contributor.author | Bokemark, L. | |
dc.contributor.author | Steinmetz, H. | |
dc.contributor.author | Ikram, M. | |
dc.contributor.author | Völzke, H. | |
dc.contributor.author | Lin, H. | |
dc.contributor.author | Plichart, M. | |
dc.contributor.author | Tuomainen, T. | |
dc.contributor.author | Desvarieux, M. | |
dc.contributor.author | McLachlan, S. | |
dc.contributor.author | Schmidt, C. | |
dc.contributor.author | Kauhanen, J. | |
dc.contributor.author | Willeit, J. | |
dc.contributor.author | Lorenz, M. | |
dc.contributor.author | Sander, D. | |
dc.date.accessioned | 2017-08-24T02:19:58Z | |
dc.date.available | 2017-08-24T02:19:58Z | |
dc.date.created | 2017-08-23T07:21:47Z | |
dc.date.issued | 2016 | |
dc.identifier.citation | Willeit, P. and Thompson, S. and Agewall, S. and Bergström, G. and Bickel, H. and Catapano, A. and Chien, K. et al. 2016. Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration. European Journal of Preventive Cardiology. 23 (2): pp. 194-205. | |
dc.identifier.uri | http://hdl.handle.net/20.500.11937/55715 | |
dc.identifier.doi | 10.1177/2047487314560664 | |
dc.description.abstract |
© 2014 European Society of Cardiology. Background Large-scale epidemiological evidence on the role of inflammation in early atherosclerosis, assessed by carotid ultrasound, is lacking. We aimed to quantify cross-sectional and longitudinal associations of inflammatory markers with common-carotid-artery intima-media thickness (CCA-IMT) in the general population. Methods Information on high-sensitivity C-reactive protein, fibrinogen, leucocyte count and CCA-IMT was available in 20 prospective cohort studies of the PROG-IMT collaboration involving 49,097 participants free of pre-existing cardiovascular disease. Estimates of associations were calculated within each study and then combined using random-effects meta-analyses. Results Mean baseline CCA-IMT amounted to 0.74 mm (SD = 0.18) and mean CCA-IMT progression over a mean of 3.9 years to 0.011 mm/year (SD = 0.039). Cross-sectional analyses showed positive linear associations between inflammatory markers and baseline CCA-IMT. After adjustment for traditional cardiovascular risk factors, mean differences in baseline CCA-IMT per one-SD higher inflammatory marker were: 0.0082 mm for high-sensitivity C-reactive protein (p < 0.001); 0.0072 mm for fibrinogen (p < 0.001); and 0.0025 mm for leucocyte count (p = 0.033). 'Inflammatory load', defined as the number of elevated inflammatory markers (i.e. in upper two quintiles), showed a positive linear association with baseline CCA-IMT (p < 0.001). Longitudinal associations of baseline inflammatory markers and changes therein with CCA-IMT progression were null or at most weak. Participants with the highest 'inflammatory load' had a greater CCA-IMT progression (p = 0.015). Conclusion Inflammation was independently associated with CCA-IMT cross-sectionally. The lack of clear associations with CCA-IMT progression may be explained by imprecision in its assessment within a limited time period. Our findings for 'inflammatory load' suggest important combined effects of the three inflammatory markers on early atherosclerosis. | |
dc.publisher | Sage Publications | |
dc.title | Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration | |
dc.type | Journal Article | |
dcterms.source.volume | 23 | |
dcterms.source.number | 2 | |
dcterms.source.startPage | 194 | |
dcterms.source.endPage | 205 | |
dcterms.source.issn | 2047-4873 | |
dcterms.source.title | European Journal of Preventive Cardiology | |
curtin.department | School of Biomedical Sciences | |
curtin.accessStatus | Fulltext not available |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |